Aqemia

Aqemia: A Leading AI-Driven Drug Discovery Platform

Aqemia is a French biotech company that leverages generative AI and quantum-inspired physics to accelerate drug discovery. Their platform combines deep learning with ultra-fast physical simulations to design novel drug candidates, enabling the discovery of innovative therapeutics for challenging targets.

The platform excels in analyzing billions of molecules in record time and predicting binding affinity with high accuracy. It also supports collaborative drug discovery programs with major pharmaceutical partners, enhancing R&D efficiency in the pharmaceutical field.

Key Features

• Generative AI for novel molecule design.
• Quantum-inspired physics-based affinity prediction.
• Ultra-fast virtual screening of billions of molecules.
• Target identification and validation support.
• Collaborative drug discovery programs with pharma partners.

Aqemia addresses major challenges in drug discovery, such as difficult-to-treat targets, making it a powerful tool for researchers and pharmaceutical companies alike.